Hasil Pencarian - Michael Nsaka

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study

    Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study oleh Hannah Schenk, Dagny Holle, Michael Nsaka, Christoph Kleinschnitz, Martin Glas, Armin Scheffler

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies

    Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies oleh Michael Nsaka, Armin Scheffler, Sebastian Wurthmann, Hannah Schenk, Christoph Kleinschnitz, Martin Glas, Dagny Holle

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience

    CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience oleh Armin Scheffler, Hannah Schenk, Sebastian Wurthmann, Michael Nsaka, Christoph Kleinschnitz, Martin Glas, Dagny Holle

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional study

    Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional study oleh Sebastian Wurthmann, Dagny Holle, Mark Obermann, Miriam Roesner, Michael Nsaka, Armin Scheffler, Christoph Kleinschnitz, Steffen Naegel

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Erenumab in highly therapy-refractory migraine patients: First German real-world evidence

    Erenumab in highly therapy-refractory migraine patients: First German real-world evidence oleh Armin Scheffler, Olga Messel, Sebastian Wurthmann, Michael Nsaka, Christoph Kleinschnitz, Martin Glas, Steffen Naegel, Dagny Holle

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis

    Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis oleh Armin Scheffler, Jale Basten, Lennart Menzel, Dominik Binz, Wolfgang Alexander Becker, Vincent Breunung, Hannah Schenk, Christoph Kleinschnitz, Michael Nsaka, Diana Lindner, Dagny Holle

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany

    Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retr... oleh Armin Scheffler, Pauline Wenzel, Merle Bendig, Astrid Gendolla, Jale Basten, Christoph Kleinschnitz, Michael Nsaka, Diana Lindner, Steffen Naegel, Philipp Burow, Robert Fleischmann, Dagny Holle

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: